Page Tools:

Malignant Liver Tumors: Current and Emerging Therapies, Second Edition

Author(s): Pierre Clavien, MD, PhD, University Hospital - Zürich, Zurich
Yuman Fong, MD, Memorial Sloan-Kettering Cancer Center
H. Kim Lyerly, MD, Duke University Medical Center
Michael A. Morse, MD, Duke University Medical Center
Alan P. Venook, MD, University of California, San Francisco, California
Details:
  • ISBN-13: 9780763718572
  • ISBN-10:0763718572
  • Hardcover    482 pages      © 2004
Price: International Sales $409.95 US List
Add to Cart

Overview

This classic reference has been completely revised and updated by a renowned team of editors to produce the most current, comprehensive, and authoritative book available on treating liver cancer. Clearly written, carefully edited, and impeccably referenced, Malignant Liver Tumors, Second Edition, provides the latest information on traditional and cutting-edge surgical approaches, new and emerging drugs and their new generation of delivery systems, radiation therapy, approach to "special" patients, and much more. Expanded to 36 comprehensive but concise chapters by more than 60 world experts, and with over 200 illustrations, this new edition is an invaluable resource for all cancer care professionals who treat patients with liver tumors.

This new edition will cover, in 36 concise chapters with over 200 illustrations, the latest drugs and their delivery systems (new generation of pumps), including biotherapies, advances in radiation oncology, and the most recent surgical approaches.  This book is an essential resource for anyone who treats cancer patients, including oncologists, radiotherapists, and surgeons.

ShowKey Features

Comprehensive section on traditional and innovative surgical techniques

The latest chemotherapeutic agents and new generation of delivery systems

In-depth coverage of new systematic treatments, including gene therapy, immunotherapies, anti-angiogenesis, and others

Approach to special patient populations, including the elderly, children, pregnant women, and cirrhotic and other medically-compromised patients

New to this Edition!

Five new chapters, including those devoted to complementary and alternative therapies, laparoscopic surgery, and new genetic/biological therapies

Over 200 high-quality photographs and line drawings

Back to top

ShowTable of Contents

Part I: EPIDEMIOLOGY, DIAGNOSIS, AND ALGORITHMS FOR TREATMENT
1. Pathology of Primary and Secondary Malignant Liver Tumors
2. Epidemiology, Etiology, and Natural History of Liver Tumors
3. Tumor Markers in Primary and Secondary Liver Tumors
4. Modalities for Imaging Liver Tumors
5. (N) Assessment of Liver Function and Mass in Cirrhotic and Noncirrhotic Livers

Part II: SYSTEMIC AND REGIONAL THERAPIES
6. Systemic Treatment of Hepatobiliary Tumors
7. Radiation Therapy for Liver Tumors
8. Transarterial Embolization for Patients with Hepatocellular Carcinoma
9.  Selective Continuous Intra-arterial Chemotherapy for Liver Tumors
10. Isolated Hepatic Perfusion

Part III: TUMOR ABLATION
11. (N) Laparoscopic Approaches to Liver Tumors
12. Resection of Hepatic Tumors: Special Emphasis on Neoadjuvant and Adjuvant Therapy
13. Repeat Resection for Liver Tumors
14. Cryoablation of Liver Tumors
15. Thermal Ablation of Liver Tumors by Radiofrequency, Microwave, and Laser Therapy
16. Ethanol and Other Percutaneous Injection Modalities in the Treatment of Liver Tumors
17. Transplantation for Liver Tumors
18.  Multimodality Treatment of Liver Neoplasms

Part IV: EMERGING THERAPIES
19. Cell- and Vaccine-Based Immunotherapy of Liver Tumors
20. (N) Viral-Based Therapies for Primary and Secondary Liver Cancer
21. (N) Local Radio Ablative Techniques for Liver Tumors
22. (N) Antibodies in the Therapy of Liver Tumors
23. (N) Novel Therapies Targeted at Signal Transduction in Liver Tumors
24. Induction of Apoptosis in Liver Tumors
25. Antiangiogenic Agents for Liver Tumors
26. (N) Alternative and Complementary Treatments

Part V:  SPECIAL TUMORS AND POPULATION AND SPECIAL CONSIDERATIONS
27. Therapy of Liver Tumors in the Cirrhotic Patient
28. Liver Metastasis from Neuroendocrine Tumors
29. Liver Tumors of Rare and Unknown Origins
30. Liver Tumors in Special Populations
31. Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection
32. Treatment of Liver Tumors in Children
33. (N) Liver Tumors in Asia
34. (N) Malignant Liver Tumors in Africa
35. (N) Hepatic Tumors in South America
36. Anesthetic Management of Liver Surgery
 


Back to top

ShowAbout the Author(s)

Pierre Clavien, MD, PhD-University Hospital - Zürich, Zurich

Professor of Surgery, Department of Visceral and Transplant Surgery, University Hospital, Zürich, Switzerland



 

 

Yuman Fong, MD-Memorial Sloan-Kettering Cancer Center

Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

H. Kim Lyerly, MD-Duke University Medical Center

Professor of Surgery, Duke University Medical Center, Durham, North Carolina

Michael A. Morse, MD-Duke University Medical Center

Assistant Professor of Medicine, Duke University Medical Center, Durham, North Carolina

Alan P. Venook, MD-University of California, San Francisco, California

Professor of Clinical Medicine, Chief, Gastrointestinal Oncology University of California at San Francisco, San Francisco, California

Back to top

ShowReviews

  • "This book is clearly written and the material is comprehensive, with an extensive list of references at the end of each chapter. The volume is concise and cutting edge in a rapidly changing field."

     

    - The British Journal of Surgery

    "This book is a joy ... This is the best book in this area that I am aware of and I thoroughly recommend it."

    -The British Journal of Surgery

    "[Malignant Liver Tumors] will be a very useful reference for anyone working in the area of liver malignancies."

    - Journal of the American College of Surgeons

    "With the excellent overall quality of the book, it is not easy to find points for criticism ... Altogether, I am very pleased to recommend this book to all those who deal with the clinical aspects of malignant liver tumors. It will be very helpful for patient care."

    - Journal of Hepatology

     

     

Back to top

ShowSamples & Additional Resources

ShowResources

Back to top